☒ |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO
|
Delaware
|
06-1681204
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
Trading Symbol
|
Name of each exchange on which registered
|
|||
Common Stock, $0.0001 par value per share
|
VERO
|
The Nasdaq Global Market
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|||
Non-accelerated filer
|
☒
|
Smaller reporting company
|
☒
|
|||
Emerging growth company
|
☒
|
Item 15. |
(a)
|
The following documents are filed as part of this report:
|
Exhibit
Number
|
Exhibit Description
|
Form
|
Date
|
Number
|
Filed
Herewith
|
|||||
Agreement and Plan or Merger and Reorganization, dated March 15, 2019, by and among Restoration Robotics, Inc., Radiant Merger Sub Ltd., and Venus Concept Ltd.
|
8-K
|
3-15-19
|
2.1
|
|||||||
Amendment No. 1, dated August 14, 2019, to the Agreement and Plan of Merger and Reorganization, dated March 15, 2019, by and among Restoration Robotics, Inc., Radiant Merger Sub Ltd., and Venus Concept Ltd.
|
8-K
|
8-20-19
|
2.1
|
|||||||
Second Amendment to the Agreement and Plan of Merger and Reorganization, dated as of October 31, 2019, by and among Restoration Robotics, Inc., Radiant Merger Sub Ltd. and Venus Concept Ltd.
|
8-K
|
10-31-19
|
2.1
|
|||||||
Master Asset Purchase Agreement between Venus Concept Ltd., the Neograft entities, Medicamat and Miriam Merkur, dated January 26, 2018.
|
10-K
|
3-30-20
|
2.4
|
|||||||
Amended and Restated Certificate of Incorporation of Restoration Robotics, Inc.
|
8-K
|
10-17-17
|
3.1
|
|||||||
Certificate of Amendment of Certificate of Incorporation of Restoration Robotics, Inc.
|
8-K
|
11-7-19
|
3.1
|
|||||||
Second Amended and Restated Bylaws of Venus Concept Inc.
|
8-K
|
11-7-19
|
3.2
|
|||||||
Description of Securities.
|
10-K
|
3-29-21
|
4.1
|
|||||||
Form of Common Stock Certificate.
|
S-1/A
|
9-18-17
|
4.2
|
|||||||
Form of 2020 Warrant.
|
10-K
|
3-29-21
|
4.3
|
|||||||
Amendment to 2019 Warrant.
|
8-K
|
3-10-20
|
4.1
|
|||||||
Form of 2019 Warrant.
|
8-K
|
11-7-19
|
4.1
|
|||||||
Form of Madryn Warrant.
|
8-K
|
11-7-19
|
4.2
|
|||||||
Form of Warrant to Purchase Stock, dated November 7, 2019, by and between Venus Concept Inc. and Solar Capital Ltd.
|
8-K
|
11-7-19
|
4.3
|
|||||||
Form of Warrant to Purchase Stock, dated November 2, 2018, by and between Restoration Robotics, Inc. and Solar Capital Ltd.
|
10-K
|
3-20-19
|
4.10
|
|||||||
Form of Warrant to Purchase Stock, dated May 19, 2015, by and between Restoration Robotics, Inc. and Oxford Finance LLC.
|
10-K
|
3-30-20
|
4.9
|
|||||||
Form of Warrant to Purchase Stock, dated November 2, 2018, by and between Restoration Robotics, Inc. and Western Alliance Bank.
|
10-K
|
3-30-20
|
4.10
|
|||||||
Form of Warrant to Purchase Stock, dated November 2, 2018, by and between Restoration Robotics, Inc. and SUNS SPV LLC.
|
10-K
|
3-30-20
|
4.11
|
|||||||
Securities Purchase Agreement, dated as of March 18, 2020, by and between Venus Concept Inc. and the investors listed therein.
|
10-K
|
3-30-20
|
4.12
|
|||||||
Registration Rights Agreement, dated as of March 18, 2020, by and between Venus Concept Inc. and the investors listed therein.
|
10-K
|
3-30-20
|
4.13
|
|||||||
Amended and Restated Investors’ Rights Agreement, dated February 7, 2013, by and among Restoration Robotics, Inc. and the investors listed therein, as amended.
|
S-1
|
9-1-17
|
10.10
|
|||||||
Registration Rights Agreement, dated November 7, 2019, by and between Venus Concept Inc. and the investors listed therein.
|
8-K
|
11-7-19
|
10.2
|
|||||||
Registration Rights Agreement, dated November 7, 2019, by and between Venus Concept Inc. and the investors listed therein.
|
8-K
|
11-7-19
|
10.15
|
Exhibit
Number
|
Exhibit Description
|
Form |
Date
|
|
Number
|
Filed
Herewith
|
||||
Registration Rights Agreement, dated as of June 16, 2020, by and between Venus Concept Inc. and Lincoln Park Capital Fund, LLC.
|
8-K
|
6-16-20
|
10.2
|
|||||||
Second Amended and Restated Loan Agreement, dated March 20, 2020, by and among Venus Concept USA Inc., Venus Concept Canada Corp., Venus Concept Inc. and City National Bank of Florida.
|
8-K
|
3- 24-20
|
10.1
|
|||||||
Second Amended and Restated Guaranty of Payment and Performance, dated as of March 20, 2020, by and between Venus Concept USA Inc., Venus Concept Canada Corp., Venus Concept Inc., and City National Bank of Florida.
|
8-K
|
3- 24-20
|
10.2
|
|||||||
Third Amended and Restated Revolving Promissory Note, dated as of March 20, 2020, by and between Venus Concept USA Inc., Venus Concept Canada Corp., Venus Concept Inc., and City National Bank of Florida.
|
8-K
|
3- 24-20
|
10.3
|
|||||||
Security Agreement, dated as of March 20, 2020, by and between Venus Concept Inc. and City National Bank of Florida.
|
8-K
|
3- 24-20
|
10.4
|
|||||||
License Agreement, dated July 25, 2006 by and between Restoration Robotics, Inc., James A. Harris, M.D. and HSC Development LLC.
|
S-1/A
|
9-22-17
|
10.7
|
|||||||
First Amendment to License Agreement, dated January 5, 2009, by and between Restoration Robotics, Inc., James A. Harris, M.D. and HSC Development LLC.
|
S-1/A
|
9-22-17
|
10.8
|
|||||||
Second Amendment to License Agreement, dated February 23, 2015, by and between Restoration Robotics, Inc., James A. Harris, M.D. and HSC Development LLC.
|
S-1/A
|
9-22-17
|
10.9
|
|||||||
Venus Concept Inc. 2019 Incentive Award Plan.
|
8-K
|
11-7-19
|
10.21
|
|||||||
Form of Stock Option Grant Notice and Stock Option Agreement under the 2019 Incentive Award Plan.
|
10-K
|
3-30-20
|
10.24
|
|||||||
2017 Incentive Award Plan.
|
S-8
|
10-17-17
|
99.7
|
|||||||
Form of Stock Option Grant Notice and Stock Option Agreement under the 2017 Incentive Award Plan.
|
S-1/A
|
9-18-17
|
10.26
|
|||||||
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2017 Incentive Award Plan.
|
S-1/A
|
9-18-17
|
10.27
|
|||||||
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2017 Incentive Award Plan.
|
S-1/A
|
9-18-17
|
10.28
|
|||||||
2017 Employee Stock Purchase Plan.
|
S-8
|
10-17-17
|
99.11
|
|||||||
Non-Employee Director Compensation Program.
|
S-1/A
|
9-18-17
|
10.35
|
|||||||
2015 Equity Incentive Plan.
|
S-8
|
10-17-17
|
99.4
|
|||||||
Form of Stock Option Grant Notice and Stock Option Agreement under 2015 Equity Incentive Plan.
|
S-1
|
9-1-17
|
10.23
|
|||||||
Form of Stock Purchase Right Grant Notice and Restricted Stock Purchase Agreement under 2015 Equity Incentive Plan.
|
S-1
|
9-1-17
|
10.24
|
|||||||
Venus Concept Ltd. 2010 Israeli Employee Share Option Plan.
|
8-K
|
11-7-19
|
10.20
|
|||||||
Employment Agreement by and between Venus Concept Ltd. and Domenic Serafino, effective January 1, 2016.
|
8-K
|
11-7-19
|
10.16
|
|||||||
Employment Agreement by and between Venus Concept Ltd. and Domenic Della Penna, effective September 5, 2017.
|
8-K
|
11-7-19
|
10.17
|
|||||||
Employment Agreement by and between Venus Concept UK, Ltd. and Søren Maor Sinay, effective August 6, 2019.
|
8-K
|
11-7-19
|
10.18
|
|||||||
Employment Agreement, dated January 24, 2020, by and between Chad A. Zaring and Venus Concept Inc.
|
8-K
|
1-30-20
|
10.1
|
|||||||
Form of Indemnification Agreement between Venus Concept Inc. and each of its directors and executive officers.
|
8-K
|
11-7-19
|
10.19
|
|||||||
Lease Agreement, dated April 16, 2012, by and between Legacy Partners I San Jose, LLC and Restoration Robotics, Inc.
|
S-1
|
9-1-17
|
10.5
|
|||||||
First Amendment to Lease Agreement, dated April 27, 2016, by and between G&I VIII Baytech LP and Restoration Robotics, Inc. and Tenant Estoppel Certificate, dated March 30, 2017, acknowledging Bridge III CA Alviso Tech Park, LLC as
successor-in-interest to Landlord thereto.
|
S-1
|
9-1-17
|
10.6
|
|||||||
Second Amendment to Lease Agreement, dated November 7, 2019, by and between Bridge III CA Alviso Tech Park, LLC and Venus Concept Inc.
|
10-K
|
3-30-20
|
10.48
|
Exhibit
Number
|
Exhibit Description
|
Form | Date | Number |
Filed
Herewith
|
|||||
Lease between 235 Investment Limited, Venus Concept Canada Corp and Venus Concept Ltd, dated March 29, 2019.
|
10-K
|
3-30-20
|
10.49
|
|||||||
Assumption and Amendment Agreement by and between Venus Concept USA Inc., and Jack Fisher ND., dated as of February 8, 2018.
|
10-K
|
3-30-20
|
10.50
|
|||||||
Head of Medical Advisory Board Agreement by and between Venus Concept Ltd. and Dr. Neil Sadick, dated as of June 1, 2016, as amended by 1st Amendment to Head of Medical Advisory Board Agreement, dated as of September 24, 2018.
|
10-K
|
3-30-20
|
10.51
|
|||||||
Quality Agreement, dated November 19, 2017, by and between Venus Concept Ltd. and R.H. Technologies Ltd.
|
10-K
|
3-30-20
|
10.53
|
|||||||
Quality Agreement, dated October 11, 2011, by and between Venus Concept Ltd. and USR Electronnic Systems Ltd. (signed December 3, 2017).
|
10-K
|
3-30-20
|
10.54
|
|||||||
Turn-Key Project Manufacturing Agreement, dated March 23, 2014, by and between Venus Concept Ltd. and USR Electronnic Systems Ltd.
|
10-K
|
3-30-20
|
10.55
|
|||||||
Quality Agreement, dated July 13/17 2018, by and between Venus Concept Ltd. and Electronique du Mazet.
|
10-K
|
3-30-20
|
10.56
|
|||||||
Intellectual Property Rights Assignment, dated February 15, 2018, by and between Venus Concept Ltd. and Electronique du Mazet.
|
10-K
|
3-30-20
|
10-57
|
|||||||
Consent to Transfer Confidentiality and Nonsolicitation Subcontracting Agreement, dated February 1, 2018, by and between Venus Concept Ltd. and Societe de Promotion et d'Equipement Medical Medicamat.
|
10-K
|
3-30-20
|
10-58
|
|||||||
Manufacturing Agreement for Consumables, dated October 26, 2018, by and between NPI Solutions and Restoration Robotics, Inc.
|
10-K
|
3-30-20
|
10-59
|
|||||||
SBA Payroll Protection Program Note dated April 21, 2020, by Venus Concepts Inc. and in favor of City National Bank of Florida.
|
8-K
|
4-30-20
|
10.2
|
|||||||
Purchase Agreement, dated as of June 16, 2020, by and between Venus Concept Inc. and Lincoln Park Capital Fund, LLC
|
8-K
|
6-16-20
|
10.1
|
|||||||
Third Amended and Restated Loan Agreement dated as of December 9, 2020, by and among the Company, Venus Concept USA Inc., Venus Concept Canada Corp. and City National Bank of Florida.
|
8-K/A
|
12-15-20
|
10.1
|
|||||||
Second Amended and Restated Security Agreement dated as of December 9, 2020 by and among the Company, Venus Concept USA Inc. and City National Bank.
|
8-K/A
|
12-15-20
|
10.2
|
|||||||
Fourth Amended and Restated Revolving Promissory Note dated as of December 9, 2020 by Venus Concept USA Inc., Venus Concept Canada Corp. and the Company in favor of City National Bank of Florida.
|
8-K/A
|
12-15-20
|
10.3
|
|||||||
Third Amended and Restated Guaranty of Payment and Performance dated as of December 9, 2020 by Venus Concept Ltd. in favor of City National Bank of Florida.
|
8-K/A
|
12-15-20
|
10.4
|
|||||||
Amendment to General Security Agreement dated as of December 9, 2020 between Venus Concept Canada Corp. and City National Bank of Florida.
|
8-K/A
|
12-15-20
|
10.5
|
|||||||
Loan and Security Agreement dated as of December 8, 2020, by and between Venus Concept USA Inc. and City National Bank.
|
8-K/A
|
12-15-20
|
10.6
|
|||||||
Promissory Note dated December 8, 2020, by Venus Concept USA Inc. in favor of City National Bank.
|
8-K/A
|
12-15-20
|
10.7
|
|||||||
Guaranty of Payment and Performance Agreement dated as of December 8, 2020 by and between the Company and City National Bank.
|
8-K/A
|
12-15-20
|
10.8
|
|||||||
Securities Exchange and Registration Rights Agreement as of December 8, 2020 by and among the Company, Venus Concept USA Inc., Venus Concept Canada Corp., Venus Concept Ltd., Madryn Health Partners, LP and the Investors.
|
8-K/A
|
12-15-20
|
10.9
|
|||||||
Secured Subordinated Convertible Note dated as of December 9, 2020 by the Company in favor of Madryn Health Partners, LP.
|
8-K/A
|
12-15-20
|
10.10
|
|||||||
Secured Subordinated Convertible Note dated as of December 9, 2020 by the Company in favor of and Madryn Health Partners (Cayman Master), LP.
|
8-K/A
|
12-15-20
|
10.11
|
|||||||
Guaranty and Security Agreement dated as of December 9, 2020 by and among the Company, Venus Concept USA, Venus Concept Canada Corp., Venus Concept Ltd. and Madryn Health Partners, LP.
|
8-K/A
|
12-15-20
|
10.12
|
Exhibit
Number
|
Exhibit Description | Form | Date | Number |
Filed
Herewith
|
|||||
Subordination of Debt Agreement dated as of December 9, 2020 by and among Madryn Health Partners, LP, Madryn Health Partners (Cayman Master), LP, City National Bank and Venus Concept Inc.
|
8-K/A
|
12-15-20
|
10.13
|
|||||||
Subordination of Debt Agreement dated as of December 9, 2020 by and among Madryn Health Partners, LP, Madryn Health Partners (Cayman Master), LP, City National Bank and Venus Concept Canada Corp.
|
8-K/A
|
12-15-20
|
10.14
|
|||||||
Subordination of Debt Agreement dated as of December 9, 2020 by and among Madryn Health Partners, LP, Madryn Health Partners (Cayman Master), LP, City National Bank and Venus Concept USA Inc.
|
8-K/A
|
12-15-20
|
10.15
|
|||||||
Code of Business Conduct and Ethics.
|
8-K
|
11-7-19
|
14.1
|
|||||||
List of Subsidiaries.
|
10-K
|
3-29-21
|
21.1
|
|||||||
Consent of MNP LLP, independent registered public accounting firm.
|
10-K
|
3-29-21
|
||||||||
Power of Attorney. Reference is made to the signature page of this Annual Report on Form 10-K.
|
10-K
|
3-29-21
|
24.1
|
|||||||
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.
|
X
|
|||||||||
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.
|
X
|
|||||||||
Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.
|
X
|
|||||||||
32.1*
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
10-K
|
3-29-21
|
32.1
|
||||||
32.2*
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
10-K
|
3-29-21
|
32.2
|
||||||
101.INS
|
XBRL Instance Document
|
10-K
|
3-29-21
|
101.INS
|
||||||
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
10-K
|
3-29-21
|
101.SCH
|
||||||
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
10-K
|
3-29-21
|
101.CAL
|
||||||
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
10-K
|
3-29-21
|
101.DEF
|
||||||
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
10-K
|
3-29-21
|
101.LAB
|
||||||
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
10-K
|
3-29-21
|
101.PRE
|
# |
Indicates management contract or compensatory plan.
|
† |
Certain confidential portions of this exhibit were omitted by means of marking such portions with asterisks because the identified confidential portions (i) are not material and (ii) would be competitively
harmful if publicly disclosed.
|
* |
The certifications attached as Exhibit 32.1 and Exhibit 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by
reference into any filing of Venus Concept Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any
general incorporation language contained in such filing.
|
Venus Concept Inc.
|
||
Date: December 22, 2021
|
By:
|
/s/ Domenic Serafino
|
Domenic Serafino
|
||
Chief Executive Officer and Director
|
1. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;
|
2. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this report;
|
3. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f)) for the registrant and have:
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c) |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and
|
(d) |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's fourth fiscal quarter that has materially affected, or is reasonably
likely to materially affect, the registrant's internal control over financial reporting; and
|
4. |
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent functions):
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record,
process, summarize and report financial information; and
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: March 29, 2021
|
By:
|
/s/ Domenic Serafino
|
Name: Domenic Serafino
|
||
Chief Executive Officer
|
||
(Principal Executive Officer)
|
1. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;
|
2. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this report;
|
3. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f)) for the registrant and have:
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c) |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and
|
(d) |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's fourth fiscal quarter that has materially affected, or is reasonably
likely to materially affect, the registrant's internal control over financial reporting; and
|
4. |
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent functions):
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record,
process, summarize and report financial information; and
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: December 22, 2021
|
By:
|
/s/ Domenic Serafino
|
Name: Domenic Serafino
|
||
Chief Executive Officer
|
||
(Principal Executive Officer)
|
1. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;
|
2. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this report;
|
3. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f)) for the registrant and have:
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c) |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and
|
(d) |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's fourth fiscal quarter that has materially affected, or is reasonably
likely to materially affect, the registrant's internal control over financial reporting; and
|
4. |
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent functions):
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record,
process, summarize and report financial information; and
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: December 22, 2021
|
By:
|
/s/ Domenic Della Penna
|
Name: Domenic Della Penna
|
||
Chief Financial Officer
|
||
(Principal Financial Officer)
|